Jian Ding, Ph.D.
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Google:
"Jian Ding"Mean distance: 16.14 (cluster 23) | S | N | B | C | P |
Parents
Sign in to add mentor| Dennis Levi | post-doc | UC Berkeley | |
| Ramesh Srinivasan | post-doc | 2004-2007 | UC Irvine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang M, Ding J, Levi DM, et al. (2022) The effect of spatial structure on binocular contrast perception. Journal of Vision. 22: 7 |
| Chopin A, Silver MA, Sheynin Y, et al. (2021) Transfer of Perceptual Learning From Local Stereopsis to Global Stereopsis in Adults With Amblyopia: A Preliminary Study. Frontiers in Neuroscience. 15: 719120 |
| Lev M, Ding J, Polat U, et al. (2021) Nearby contours abolish the binocular advantage. Scientific Reports. 11: 16920 |
| Ding J, Levi DM. (2020) A unified model for binocular fusion and depth perception. Vision Research. 180: 11-36 |
| Xia ZJ, Ji YC, Sun DQ, et al. (2020) SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors. Acta Pharmacologica Sinica |
| Martín S, Portela JA, Ding J, et al. (2020) Evaluation of a Virtual Reality implementation of a binocular imbalance test. Plos One. 15: e0238047 |
| Wang L, Ai J, Shen Y, et al. (2020) Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143-50]. Cancer Letters |
| Xiang HY, Chen YH, Wang Y, et al. (2020) Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives. Bioorganic & Medicinal Chemistry Letters. 127194 |
| Chen Y, Bai G, Ning Y, et al. (2020) Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma. European Journal of Medicinal Chemistry. 190: 112092 |
| Li L, Huang M, Li L, et al. (2020) Abstract 3760: HH2710, a highly potent and selective erk1/2 inhibitor for the treatment of mapk mutant tumors Immunology. 80: 3760-3760 |